Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide

NCT00463983 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER_GOV

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: octreotide

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France